Wexford Capital LP Neuronetics, Inc. Call Options Transaction History
Wexford Capital LP
- $638 Million
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding STIM
# of Institutions
104Shares Held
21.8MCall Options Held
1.57MPut Options Held
176K-
Vanguard Group Inc Valley Forge, PA2.83MShares$5.58 Million0.0% of portfolio
-
Ubs Group Ag2.16MShares$4.26 Million0.0% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.82MShares$3.59 Million0.01% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA1.74MShares$3.42 Million1.44% of portfolio
-
Masters Capital Management LLC Atlanta, GA1MShares$1.97 Million0.1% of portfolio
About Neuronetics, Inc.
- Ticker STIM
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 27,022,800
- Market Cap $53.2M
- Description
- Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...